Mrs Wendi Jo Wood, PT | |
300 Park St, Stevensville, MT 59870-2603 | |
(406) 777-2494 | |
Not Available |
Full Name | Mrs Wendi Jo Wood |
---|---|
Gender | Female |
Speciality | Physical Therapist - Pediatrics |
Location | 300 Park St, Stevensville, Montana |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003023144 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2251P0200X | Physical Therapist - Pediatrics | 1692 (Montana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Wendi Jo Wood, PT 5514 Circle Dr, Florence, MT 59833-6636 Ph: (406) 273-4605 | Mrs Wendi Jo Wood, PT 300 Park St, Stevensville, MT 59870-2603 Ph: (406) 777-2494 |
News Archive
"A new report from the Kaiser Family Foundation examines how countries are responding to and implementing the women, girls, and gender equality principle of the U.S. Global Health Initiative (GHI)," an email alert from the Foundation states, noting, "This principle, one of seven core principles of the GHI, aims to sharpen the focus on women and girls across U.S. government global health efforts."
InDevR announced today that it will pursue proof of concept development for new VaxArray potency assays for measles and rubella vaccines sponsored by the Bill & Melinda Gates Foundation.
The Canadian Association of Radiologists (CAR) recently contributed to a report produced by the Health Council of Canada (HCC) entitled "Decisions, Decisions: Family Doctors as Gatekeepers in the Use of Prescription Drugs and Diagnostic Imaging in Canada." This report, which was released today, supports one of the CAR's main objectives: to implement medical imaging guidelines at a national level to guide physicians in selecting the most effective diagnostic imaging exam the first time.
Biovest International, Inc. (Other OTC:BVTI) today announced at the Active Immunotherapeutics Forum in Barcelona, Spain, that the Company is targeting mantle cell lymphoma, in addition to follicular lymphoma, as a next indication for its personalized cancer vaccine, BiovaxID. At the conference, the Company reviewed positive data from an open label Phase II mantle cell lymphoma clinical trial and reported plans to meet with the FDA later this year to discuss a pathway to seek regulatory approval for this hematological indication for which there is no current consensus standard-of-care.
› Verified 6 days ago
Corrine F Campbell, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 4828 Eastside Hwy, Suite 101, Stevensville, MT 59870 Phone: 406-777-2679 Fax: 406-777-3586 | |
Mrs. Amber Coulter, P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 3802 Eastside Hwy, Stevensville, MT 59870 Phone: 406-777-3523 | |
Dustin Lind, DPT, CSCS Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 212 Main St, Stevensville, MT 59870 Phone: 406-777-5354 | |
Holly Warner, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 3802 Eastside Hwy, Stevensville, MT 59870 Phone: 406-777-3523 Fax: 406-777-7042 | |
Tracy Devall, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 3802 Eastside Hwy, Stevensville, MT 59870 Phone: 406-777-3523 Fax: 406-777-3523 | |
Timothy Nielsen, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3802 Eastside Hwy, Stevensville, MT 59870 Phone: 406-777-3523 Fax: 406-777-3523 |